(Jimenez et al. 2010) Finally, in a case-control study of patients with MASLD and healthy controls, serum TMAO levels correlated with serum total bile acids and hepatic mRNA expression of cholesterol 7 alpha hydroxylase (CYP7A1). Here, CYP7A1 is linked to metabolic dysfunction-associated steatotic liver disease.